Seattle Genetics bladder cancer drug succeeds in Phase 2 trial - BioPharma Dive https://t.co/NSIiFyL0ww — IDRO (@IDROOhio) March 29, 2019
Seattle Genetics bladder cancer drug succeeds in Phase 2 trial - BioPharma Dive https://t.co/NSIiFyL0ww
No comments:
Post a Comment